Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cutaneous and Ocular Toxicology|November 7, 2008
Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cellsMaria A Pino, Blase BillackMedical Cannabis and Cannabinoids|June 13, 2025
Physicians' Knowledge, Attitudes, and Perceptions about Medical Cannabis in the United States: A Scoping ReviewEleanor Yusupov, Stephanie Lopez, Maria A PinoCutaneous and Ocular Toxicology|June 6, 2013
Selected ebselen analogs reduce mechlorethamine toxicity in vitroMaria A Pino, Magdalena Pietka-Ottlik, Blase BillackInternational Journal of Osteopathic Medicine : IJOM|November 8, 2021
Perceptions of COVID-19 vaccines among osteopathic medical students (OMS)Taysir Al Janabi, Ravi Chinsky, Maria A PinoArhiv Za Higijenu Rada I Toksikologiju|April 25, 2013
Ebselen analogues reduce 2-chloroethyl ethyl sulphide toxicity in A-431 cellsMaria A Pino, Magdalena Pietka-Ottlik, Blase BillackMedical Science Educator|August 30, 2021
What Physicians Wished They Would Have Learned in Medical School: a SurveyJudith M Binstock, Maria A Pino, Louis H PrimaveraMedical Science Educator|August 30, 2021
Are Medical Students Prepared to Model Healthy Behaviors for Their Future Patients? A Survey Comparing Aged-Matched PeersLisa Greco, Michael Gindi, Eleanor Yusupov, et al.Interdisciplinary Toxicology|November 26, 2019
Assessment of the time-dependent dermatotoxicity of mechlorethamine using the mouse ear vesicant modelBenedette J Cuffari, Hemanta C Rao Tumu, Maria A Pino, et al.Journal of Biochemical and Molecular Toxicology|May 8, 2013
Ebselen reduces the toxicity of mechlorethamine in A-431 cells via inhibition of apoptosisAnju Lulla, Maria A Pino, Magdalena Piętka-Ottlik, et al.Drug and Chemical Toxicology|September 27, 2018
Ebselen oxide attenuates mechlorethamine dermatotoxicity in the mouse ear vesicant modelHemanta C Rao Tumu, Benedette J Cuffari, Maria A Pino, et al.Pageof 2